Evidence map›Paper›PMID 32607904›Full record

ArticleJournal of digital imaging2020

Classification of Skin Lesions into Seven Classes Using Transfer Learning with AlexNet.

Khalid M Hosny, Mohamed A Kassem, Mohamed M Fouad

Abstract read
In one paragraph

Article in Journal of digital imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A Review Paper about Deep Learning for Medical Image Analysis.Computational and mathematical methods in medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khalid M HosnyDepartment of Information Technology, Faculty of Computers and Informatics, Zagazig, University, Zagazig 44519, Egypt. k_hosny@yahoo.com.ORCID 0000-0001-8065-8977
Mohamed A KassemDepartment of Robotics and Intelligent Machines, Faculty of Artificial Intelligence, KafrElSheikh University, KafrElSheikh, 33511, Egypt.
Mohamed M FouadDepartment of Electronics and Communication, Faculty of Engineering, Zagazig University, Zagazig 44519, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is deadly skin cancer. There is a high similarity between different kinds of skin lesions, which lead to incorrect classification. Accurate classification of a skin lesion in its early stages saves human life. In this paper, a highly accurate method proposed for the skin lesion classification process. The proposed method utilized transfer learning with pre-trained AlexNet. The parameters of the original model used as initial values, where we randomly initialize the weights of the last three replaced layers. The proposed method was tested using the most recent public dataset, ISIC 2018. Based on the obtained results, we could say that the proposed method achieved a great success where it accurately classifies the skin lesions into seven classes. These classes are melanoma, melanocytic nevus, basal cell carcinoma, actinic keratosis, benign keratosis, dermatofibroma, and vascular lesion. The achieved percentages are 98.70%, 95.60%, 99.27%, and 95.06% for accuracy, sensitivity, specificity, and precision, respectively.

Indexed as

MelanomaSkin DiseasesSkin NeoplasmsDermoscopyHumansMachine LearningAlexNetClassification of skin lesionsISIC 2018MelanomaTransfer learning

Identifiers

PMID32607904
PMCPMC7573031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.